1,854
Views
13
CrossRef citations to date
0
Altmetric
Articles

External validation of prognostic models for preeclampsia in a Dutch multicenter prospective cohort

ORCID Icon, , , , , , , , , , , , , , , , , , , ORCID Icon & show all
Pages 78-88 | Received 29 Jun 2018, Accepted 13 Feb 2019, Published online: 20 Mar 2019

References

  • Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130–137.
  • Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013;347:f6564.
  • Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the international society for the study of hypertension in pregnancy (ISSHP). Hypertens Pregnancy. 2001;20:IX–XIV.
  • Roberge S, Nicolaides KH, Demers S, et al. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obs Gynecol. 2013;41:491–499.
  • Hofmeyr JG, Lawrie TA, Atallah AN, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2018;6:CD001059.
  • LeFevre ML. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. preventive services task force recommendation statement. Ann Intern Med. 2014;161:819–826.
  • National Institute for Health and Care Excellence. Hypertension in pregnancy. NICE guideline CG107; 2011.
  • Kleinrouweler CE, Cheong-See FM, Collins GS, et al. Prognostic models in obstetrics: available, but far from applicable. Am J Obstet Gynecol. 2016;214:79–90.e36.
  • Brunelli VB, Prefumo F. Quality of first trimester risk prediction models for pre-eclampsia: a systematic review. BJOG. 2015;122:904–914.
  • Al-Rubaie Z, Askie L, Ray J, et al. The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review. BJOG. 2016;123(9):1441–1452.
  • Lamain-de Ruiter M, Kwee A, Naaktgeboren CA, et al. External validation of prognostic models to predict risk of gestational diabetes mellitus in one Dutch cohort: prospective multicentre cohort study. BMJ. 2016;354:i4338.
  • Moons KGM, Altman DG, Reitsma JB, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162:W1.
  • Akolekar R, Syngelaki A, Sarquis R, et al. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat Diagn. 2011;3:66–74.
  • Baschat AA, Magder LS, Doyle LE, et al. Prediction of preeclampsia utilizing the first trimester screening examination. Am J Obstet Gynecol. 2014;211:514.e1–7.
  • Crovetto F, Figueras F, Triunfo S, et al. First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors. Prenat Diagn. 2015;35:183–191.
  • Crovetto F, Figueras F, Triunfo S, et al. Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy. Fetal Diagn Ther. 2014;35:258–266.
  • Giguere Y, Masse J, Theriault S, et al. Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers. BJOG. 2015;122:402–410.
  • Kuc S, Koster MP, Pennings JL, et al. Metabolomics profiling for identification of novel potential markers in early prediction of preeclampsia. PLoSOne. 2014;9:e98540.
  • Kuc S, Koster MPH, Franx A, et al. Maternal characteristics, mean arterial pressure and serum markers in early prediction of preeclampsia. PLoS One. 2013;8:e63546.
  • Myatt L, Clifton RG, Roberts JM, et al. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol. 2012;119:1234–1242.
  • Odibo AO, Zhong Y, Goetzinger KR, et al. First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia. Placenta. 2011;32:598–602.
  • Plasencia W, Maiz N, Bonino S, et al. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obs. 2007;30:742–749.
  • Poon LC, Kametas NA, Chelemen T, et al. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. JHumHypertens. 2010;24:104–110.
  • Lc P, Maiz N, Valencia C, et al. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obs. 2009;33:23–33.
  • Poon LCY, Kametas NA, Pandeva I, et al. Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia. Hypertension. 2008;51:1027–1033.
  • Scazzocchio E, Figueras F, Crispi F, et al. Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting. Am J Obstet Gynecol. 2013;208:203.e1–203.e10.
  • Goetzinger KR, Singla A, Gerkowicz S, et al. Predicting the risk of pre-eclampsia between 11 and 13 weeks’ gestation by combining maternal characteristics and serum analytes, PAPP-A and free beta-hCG. Prenat Diagn. 2010;30:1138–1142.
  • Goetzinger K, Tuuli M, Cahill A, et al. Development and validation of a risk factor scoring system for first-trimester prediction of pre-eclampsia. Am J Perinatol. 2013;208:S300.
  • Syngelaki A, Bredaki FE, Vaikousi E, et al. Body mass index at 11-13 weeks’ gestation and pregnancy complications. Fetal Diagn Ther. 2011;30:250–265.
  • Donders ART, van der Heijden GJMG, Stijnen T, et al. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59:1087–1091.
  • Rubin D. Multiple imputation for non response in surveys. New York:  John Wiley & Sons Inc.; 1987.
  • Steyerberg EW, Borsboom GJJM, van Houwelingen HC, et al. Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med. 2004;23:2567–2586.
  • Janssen KJM, Vergouwe Y, Kalkman CJ, et al. A simple method to adjust clinical prediction models to local circumstances. Can J Anaesth. 2009;56:194–201.
  • Vergouwe Y, Moons KGM, Steyerberg EW. External validity of risk models: use of benchmark values to disentangle a case-mix effect from incorrect coefficients. Am J Epidemiol. 2010;172:971–980.
  • Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21:128–138.
  • Harrel F. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer-Verlag; 2001.
  • Bartsch E, Medcalf KE, Park AL, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;i1753.
  • Rolnik DL, Wright D, Poon LC, et al. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017;50(4):492–495.
  • Oliveira N, Magder LS, Blitzer MG, et al. First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort. Ultrasound Obs. 2014;44:279–285.
  • Farina A, Rapacchia G, Sterrantion AF, et al. Prospective evaluation of ultrasound and biochemical-based multivariable models for the prediction of late pre-eclampsia. Prenat Diagn. 2011;31:1147–1152.
  • Herraiz I, Arbu J, Cama I, et al. Application of a first-trimester prediction model for pre-eclampsia based on uterine arteries and maternal history in high-risk pregnancies. Prenat Diagn. 2009;12:1123–1129.
  • Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613–622.